How to get NERLYNX

NERLYNX is available through specific specialty pharmacies. To learn about reimbursement, download the form below.

Specialty Pharmacy List Download

  • AcariaHealth

    • T: (800) 511-5144

    • F: (877) 541-1503

    • www.acariahealth.com

    • Hours of operation: M-F, 8 am–10 pm (ET)

  • Accredo® Health Group, Inc.

    • T: (877) 732-3431

    • F: (866) 352-3973

    • www.accredo.com

    • Hours of operation: M-F, 8 am–11 pm (ET)

  • Biologics, Inc.

    • T: (800) 850-4306

    • F: (800) 823-4506

    • www.biologicsinc.com

    • Hours of operation: M-F, 8 am–8 pm (ET)

  • CVS Caremark Specialty Pharmacy

  • Diplomat Specialty Pharmacy

    • T: (877) 977-9118

    • F: (800) 550-6272

    • www.diplomatpharmacy.com

    • Hours of operation: M-F, 9 am–9 pm (ET); Sat., 9 am–5 pm (ET)

  • Onco360®

    • T: (877) 662-6633

    • F: (877) 662-6355

    • www.onco360.com

    • Hours of operation: M-F, 8 am–7 pm (ET); Sat., 9 am–2 pm (ET)

National Drug Code (NDC)

NERLYNX 40 mg film-coated tablets
Package Size: 180 tablets
NDC: 70437-240-18

IMPORTANT SAFETY INFORMATION

NERLYNX® (neratinib) tablets, for oral use

INDICATIONS AND USAGE: NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

CONTRAINDICATIONS: None

WARNINGS AND PRECAUTIONS:

ADVERSE REACTIONS: The most common adverse reactions (≥ 5%) were diarrhea, nausea, abdominal pain, fatigue, vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, AST or ALT increase, nail disorder, dry skin, abdominal distention, epistaxis, weight decreased and urinary tract infection.

To report SUSPECTED ADVERSE REACTIONS, contact Puma Biotechnology, Inc. at 1-844-NERLYNX (1-844-637-5969) and www.NERLYNX.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS:

USE IN SPECIFIC POPULATIONS:

For Full Prescribing Information, please click here.